While studies of MR blockade in obese mice have shown benefits on adipose tissue dysfunction [15, 20], clinical trials in humans of MR blockers specifically investigating its effects in obesity do not exist. The gene discussed is NR3C2; the disease is obesity due to melanocortin 4 receptor deficiency.